Bacterin's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Bacterin International Holdings, Inc. (BONE)

Q2 2012 Results Earnings Call

August 9, 2012 4:30 PM ET

Executives

John Gandolfo – Chief Financial Officer

Guy Cook – Founder and CEO

Analysts

Matt O'Brien – William Blair

Nathan Cali – Noble Financial

Anthony Vendetti – Maxim Group

Bruce Jackson – Northland Capital Markets

Greg Garner – Singular Research

Presentation

John Gandolfo

Good afternoon. And thank you for participating in today’s conference call to discuss Bacterin’s Second Quarter Financial Results for the period ended June 30, 2012. My name is John Gandolfo. I’m the Chief Financial Officer of Becterin and with me today is Guy Cook, our Chief Executive Officer and Founder. Following Guy’s remarks as well as my own, we will open up the call for your questions.

Before the conclusion of today’s call, I’ll provide the necessary precautions regarding forward-looking statements made by management during this call. I would like remind everyone that the replay of this call will be available for one month starting later this evening. A webcast replay will also be available via the link provided in today’s press release, as well as at the Investor section of our website at www.bacterin.com.

Now, I would like to turn the call over to our Chief Executive Officer, Guy Cook.

Guy Cook

Thank you, John. Good afternoon, everyone. Thank you for joining us today to discuss our second quarter 2012 results. We issued a press release this afternoon announcing our earnings results.

Revenue for the quarter was $8.2 million, compared to $7.8 million in the previous quarter, an increase of 9%, compared to $7.5 million in the second quarter of 2011. Excluding the $1.2 million stocking order sale included in our second quarter 2012 revenue figure, second quarter 2012 revenues increased 30% over second quarter 2011.

If you liked this article you might like

4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More

3 Stocks Advancing The Drugs Industry

Why Bacterin International (BONE) Is Gaining Today

3 More Under-$10 Stocks Moving Higher

8 Stocks Under $10 Surging Higher